Skip to content

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

Four doses of PrEP a week may be enough to protect

Detail from iPrEx materials (www.globaliprex.com).

A tale of two trials: how adherence is everything in PrEP

Jared Baeten. Photo by Gus Cairns / aidsmap.com

FDA updates guidance for use of HIV and hepatitis C protease inhibitors with statins

World Health Organization issues new policy to step up TB/HIV efforts

HIV and TB in Practice for nurses

Will treatment as prevention make a difference to the UK epidemic? Health promoters respond

PrEP needs more study before being provided, UK physicians conclude

Hepatitis C subtype-1b and carriage of IL28B gene associated with improved treatment responses in HIV-co-infected patients